Hasloh, Germany

Anne-Christin Worthmann


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Anne-Christin Worthmann

Introduction

Anne-Christin Worthmann is a notable inventor based in Hasloh, Germany. She has made significant strides in the field of dermatology, particularly in the treatment of atopic dermatitis. Her work has garnered attention for its innovative approach to skin care and medicinal applications.

Latest Patents

Worthmann holds a patent for a cosmetic or dermatological preparation aimed at the prophylaxis and treatment of atopic dermatitis. This patent focuses on agonists for the TRPM-8 receptor, specifically utilizing substances such as linalool, geraniol, hydroxycitronellal, WS-3, WS-23, Frescolat MAG, Frescolat ML, Coolact P, and Cooling Agent 10. These substances are designed for use as medicaments to counter atopic dermatitis, showcasing her commitment to advancing dermatological treatments.

Career Highlights

Anne-Christin Worthmann is currently employed at Beiersdorf AG, a company renowned for its dedication to skin care and personal care products. Her role at Beiersdorf AG allows her to contribute to the development of innovative solutions that address common skin conditions. Worthmann's expertise and dedication have positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Worthmann has collaborated with esteemed colleagues such as Gitta Neufang and Torsten Schlaeger. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking products.

Conclusion

Anne-Christin Worthmann's contributions to the field of dermatology through her innovative patent and work at Beiersdorf AG highlight her as a leading figure in skin care research. Her dedication to improving treatments for atopic dermatitis reflects her commitment to enhancing the quality of life for individuals affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…